Britton Russell

Britton Russell is the Chief Financial Officer at Umoja Biopharma. Britton previously held Chief Financial Officer positions at Parse Biosciences, a single-cell sequencing company, and Genapsys, a DNA sequencing company. Prior, Britton served as Senior Vice President of Finance at ArcherDX, a genomic analysis company and later Invitae, after it acquired ArcherDX. He has also held a diverse range of corporate finance roles at AstraZeneca, Genentech/Roche, and Royal Dutch Shell.
 
Britton holds an MBA from Rice University, and a BS in Finance and a BA in Business and Sustainability from Arizona State University.